Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 VaccinePRNewsWire • 05/03/21
This Huge Win Could Boost Novavax's Fortunes -- and It Has Nothing to Do With COVID-19The Motley Fool • 04/27/21
Novavax to Host Conference Call to Discuss First Quarter Financial Results and Operational Highlights on May 10, 2021PRNewsWire • 04/23/21
Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The LancetPRNewsWire • 04/23/21
Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine WoesThe Motley Fool • 04/21/21
How J&J's Coronavirus Vaccine Fiasco Could Benefit Novavax And OthersInvestors Business Daily • 04/15/21
How Soon Will Novavax File for Emergency Use Authorization for Its COVID Vaccine?The Motley Fool • 04/15/21
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine CombinationsPRNewsWire • 04/14/21